India to Flood Market With Low‑Cost Semaglutide Generics, Expanding Global Access to Obesity Treatments

India's expiry of semaglutide patents opens the door to low‑cost generic Ozempic/Wegovy‑style injections, potentially making effective weight‑loss treatments far more affordable. Multiple Indian manufacturers a...



























